Toward harmonized reporting of Alzheimer’s disease biomarkers in clinical practice
The principles of harmonized reporting for Alzheimer’s disease biomarkers and a structured framework for standardized clinical neurochemistry reports are discussed and a structured framework for standardized clinical neurochemistry reports is proposed.